Defining the optimal activated clotting times during percutaneous coronary intervention: aggregate results from 6 randomized, controlled trials.
Helft
G
G
Beygui
F
F
le Feuvre
C
C
Metzger
J P
JP
D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects; D001777:Blood Coagulation / Q000187:drug effects; D003627:Data Interpretation, Statistical; D004305:Dose-Response Relationship, Drug; D023381:Endpoint Determination / Q000706:statistics & numerical data; D006493:Heparin / Q000494:pharmacology; D006801:Humans; D016032:Randomized Controlled Trials as Topic / Q000706:statistics & numerical data; D012306:Risk; D014914:Whole Blood Coagulation Time
D006493:Heparin